<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Causal Inference, Biomarker Discovery, Graph Neural Network, Feature Selection - Health AI Hub</title>
    <meta name="description" content="This paper introduces Causal-GNN, a novel method for stable biomarker discovery from high-throughput transcriptomic data, addressing the limitations of existing">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Causal Inference, Biomarker Discovery, Graph Neural Network, Feature Selection</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.13295v1" target="_blank">2511.13295v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-17
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Chaowang Lan, Jingxin Wu, Yulong Yuan, Chuxun Liu, Huangyi Kang, Caihua Liu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.QM, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.13295v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.13295v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces Causal-GNN, a novel method for stable biomarker discovery from high-throughput transcriptomic data, addressing the limitations of existing methods that often neglect gene-gene regulatory relationships and lack stability. By integrating causal inference with multi-layer graph neural networks, particularly through GNN-based propensity scoring, the method achieves consistently high predictive accuracy and identifies more stable and biologically interpretable biomarkers. This robust tool holds strong potential for advancing precision medicine by providing more reliable insights into disease mechanisms.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate and stable biomarker discovery is fundamental for advancing precision medicine, enabling personalized diagnostics, prognostic predictions, and targeted therapeutic strategies. By providing a method to identify biomarkers with stronger causal links and greater stability, this research directly contributes to more reliable clinical decision-making and the development of effective, patient-specific interventions.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper develops a Causal Graph Neural Network (Causal-GNN) which integrates causal inference and GNNs to identify stable and biologically interpretable biomarkers from transcriptomic data. This is a direct AI application designed to enhance biomarker discovery, a critical component for personalized treatment strategies in precision medicine and other medical applications.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical challenge of biomarker discovery from transcriptomic data, specifically the issues of neglected gene-gene regulatory relationships and lack of stability in existing methods.</li>
                    
                    <li>Introduces Causal-GNN, a novel methodology that integrates causal inference principles with multi-layer Graph Neural Networks (GNNs).</li>
                    
                    <li>Key innovation involves the incorporation of causal effect estimation to identify stable biomarkers and a GNN-based propensity scoring mechanism that leverages cross-gene regulatory networks.</li>
                    
                    <li>Demonstrates consistently high predictive accuracy across four distinct datasets and four independent classifiers, highlighting its robustness and generalizability.</li>
                    
                    <li>Enables the identification of more stable biomarkers compared to traditional methods, which is crucial for clinical translation and reliability.</li>
                    
                    <li>Positions Causal-GNN as a robust, efficient, and biologically interpretable tool for biomarker discovery.</li>
                    
                    <li>Highlights the strong potential for broad application across various medical disciplines, particularly in precision medicine.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The Causal-GNN method integrates causal inference with multi-layer Graph Neural Networks (GNNs). It incorporates causal effect estimation to specifically identify stable biomarkers. A core component is a GNN-based propensity scoring mechanism, which leverages cross-gene regulatory networks to account for confounding factors and estimate causal effects, thereby moving beyond mere correlative relationships.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The Causal-GNN method consistently achieved high predictive accuracy across four distinct datasets and four independent classifiers. Furthermore, it demonstrated superior capability in identifying more stable biomarkers compared to traditional discovery methods, suggesting a reduction in spurious correlations and an increase in biological reliability.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This method could lead to the development of more reliable diagnostic tests, prognostic indicators, and predictive tools for therapeutic response in various diseases. By identifying robust, causally linked biomarkers, it can inform the design of targeted therapies, improve patient stratification, and accelerate the transition towards truly personalized medicine, reducing the risk of ineffective treatments or adverse events.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The provided abstract does not explicitly state any limitations or caveats of the Causal-GNN method.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract broadly suggests the tool's strong potential for broad application across medical disciplines, implying future work in validating its utility in diverse disease contexts and clinical settings. Specific technical future directions are not explicitly mentioned.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Genetics</span>
                    
                    <span class="tag">Pharmacogenomics</span>
                    
                    <span class="tag">Diagnostics</span>
                    
                    <span class="tag">Personalized Medicine</span>
                    
                    <span class="tag">Systems Biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Biomarker Discovery</span>
                    
                    <span class="tag tag-keyword">Causal Inference</span>
                    
                    <span class="tag tag-keyword">Graph Neural Network (GNN)</span>
                    
                    <span class="tag tag-keyword">Transcriptomics</span>
                    
                    <span class="tag tag-keyword">Precision Medicine</span>
                    
                    <span class="tag tag-keyword">Feature Selection</span>
                    
                    <span class="tag tag-keyword">Gene Regulatory Networks</span>
                    
                    <span class="tag tag-keyword">Stability</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Biomarker discovery from high-throughput transcriptomic data is crucial for advancing precision medicine. However, existing methods often neglect gene-gene regulatory relationships and lack stability across datasets, leading to conflation of spurious correlations with genuine causal effects. To address these issues, we develop a causal graph neural network (Causal-GNN) method that integrates causal inference with multi-layer graph neural networks (GNNs). The key innovation is the incorporation of causal effect estimation for identifying stable biomarkers, coupled with a GNN-based propensity scoring mechanism that leverages cross-gene regulatory networks. Experimental results demonstrate that our method achieves consistently high predictive accuracy across four distinct datasets and four independent classifiers. Moreover, it enables the identification of more stable biomarkers compared to traditional methods. Our work provides a robust, efficient, and biologically interpretable tool for biomarker discovery, demonstrating strong potential for broad application across medical disciplines.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>